{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:23:49Z","timestamp":1792686229341,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jacep.2024.09.038","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T14:07:33Z","timestamp":1737986853000},"page":"71-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Left Atrial Appendage Occlusion in\u00a0Patients With Atrial Fibrillation and\u00a0Hemodialysis"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5234-744X","authenticated-orcid":false,"given":"Lukas","family":"Urbanek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar H.","family":"Heine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Reddavid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Saw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwanari","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek Y.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Galea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz","family":"R\u00e4ber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Sedaghat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3837-3462","authenticated-orcid":false,"given":"Domenico G.","family":"Della Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5487-0728","authenticated-orcid":false,"given":"Andrea","family":"Natale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Fassini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Tondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shephal K.","family":"Doshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy S.","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1356-0037","authenticated-orcid":false,"given":"Ralph Stephan","family":"von Bardeleben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0884-6572","authenticated-orcid":false,"given":"Felix","family":"Kreidel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5347-9906","authenticated-orcid":false,"given":"Boris","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.jacep.2024.09.038_bib1","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1093\/eurheartj\/ehy060","article-title":"Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"39","author":"Turakhia","year":"2018","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jacep.2024.09.038_bib2","first-page":"83","article-title":"Thromboembolic and bleeding risk in atrial fibrillation patients with chronic kidney disease: role of anticoagulation therapy","volume":"10","author":"Magnocavallo","year":"2020","journal-title":"J\u00a0Clin Med"},{"issue":"5","key":"10.1016\/j.jacep.2024.09.038_bib3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2020","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jacep.2024.09.038_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169400","article-title":"Prevalence of atrial fibrillation and antithrombotic therapy in hemodialysis patients: cross-sectional results of the Vienna Investigation of Atrial Fibrillation and Thromboembolism in Patients on Hemodialysis (VIVALDI)","volume":"12","author":"Konigsbrugge","year":"2017","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.jacep.2024.09.038_bib5","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jacc.2020.01.019","article-title":"Oral anticoagulation and cardiovascular outcomes in patients with atrial fibrillation and end-stage renal disease","volume":"75","author":"Pokorney","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.jacep.2024.09.038_bib6","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.jacep.2024.09.038_bib7","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.jacep.2024.09.038_bib8","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.jacep.2024.09.038_bib9","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.jacc.2014.09.051","article-title":"Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study","volume":"64","author":"Bonde","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jacep.2024.09.038_bib10","first-page":"123","article-title":"Stroke prophylaxis in patients with atrial fibrillation and end-stage renal disease","volume":"9","author":"van Zyl","year":"2020","journal-title":"J\u00a0Clin Med"},{"issue":"7","key":"10.1016\/j.jacep.2024.09.038_bib11","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1105594","article-title":"Stroke and bleeding in atrial fibrillation with chronic kidney disease","volume":"367","author":"Olesen","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.jacep.2024.09.038_bib12","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1093\/ndt\/gfab060","article-title":"Anticoagulation management in hemodialysis patients with atrial fibrillation: evidence and opinion","volume":"37","author":"De Vriese","year":"2022","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.jacep.2024.09.038_bib13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/CIRCULATIONAHA.122.062779","article-title":"A\u00a0randomized controlled trial comparing apixaban with the vitamin K antagonist phenprocoumon in patients on chronic hemodialysis: the AXADIA-AFNET 8 study","volume":"147","author":"Reinecke","year":"2023","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.jacep.2024.09.038_bib14","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1161\/CIRCULATIONAHA.121.054990","article-title":"Apixaban for patients with atrial fibrillation on hemodialysis: a multicenter randomized controlled trial","volume":"146","author":"Pokorney","year":"2022","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jacep.2024.09.038_bib15","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1681\/ASN.2020111566","article-title":"Safety and efficacy of vitamin K antagonists versus rivaroxaban in hemodialysis patients with atrial fibrillation: a multicenter randomized controlled trial","volume":"32","author":"De Vriese","year":"2021","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"25","key":"10.1016\/j.jacep.2024.09.038_bib16","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.jacc.2013.03.035","article-title":"Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology)","volume":"61","author":"Reddy","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.jacep.2024.09.038_bib17","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","article-title":"Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation","volume":"75","author":"Osmancik","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jacep.2024.09.038_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.jacep.2024.09.038_bib19","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.112.114389","article-title":"Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) trial","volume":"127","author":"Reddy","year":"2013","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jacep.2024.09.038_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2021.10.023","article-title":"4-Year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation","volume":"79","author":"Osmancik","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jacep.2024.09.038_bib21","article-title":"Practical guide on left atrial appendage closure for the non-implanting physician: an international consensus paper","volume":"26","author":"Potpara","year":"2024","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.jacep.2024.09.038_bib22","first-page":"4","article-title":"Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies","volume":"19","author":"Tzikas","year":"2017","journal-title":"Europace"},{"issue":"5","key":"10.1016\/j.jacep.2024.09.038_bib23","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.hrthm.2023.01.007","article-title":"SCAI\/HRS expert consensus statement on transcatheter left atrial appendage closure","volume":"20","author":"Saw","year":"2023","journal-title":"Heart Rhythm"},{"issue":"23","key":"10.1016\/j.jacep.2024.09.038_bib24","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.jacep.2024.09.038_bib25","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","article-title":"Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182,678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study","volume":"33","author":"Friberg","year":"2012","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.jacep.2024.09.038_bib26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2010.09.024","volume":"57","author":"Lip","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9689","key":"10.1016\/j.jacep.2024.09.038_bib27","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.jacep.2024.09.038_bib28","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.jcin.2023.06.022","article-title":"3-Year outcomes from the Amplatzer Amulet Left Atrial Appendage Occluder Randomized Controlled Trial (Amulet IDE)","volume":"16","author":"Lakkireddy","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"issue":"31","key":"10.1016\/j.jacep.2024.09.038_bib29","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1093\/eurheartj\/ehv730","article-title":"Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry","volume":"37","author":"Boersma","year":"2016","journal-title":"Eur Heart J"},{"issue":"13","key":"10.1016\/j.jacep.2024.09.038_bib30","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jacc.2019.12.040","article-title":"The NCDR Left Atrial Appendage Occlusion Registry","volume":"75","author":"Freeman","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.jacep.2024.09.038_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad315","article-title":"Prognostic value of chronic kidney disease in patients undergoing left atrial appendage occlusion","volume":"25","author":"Della Rocca","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2024.09.038_bib32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijcard.2018.03.083","article-title":"Implant success and safety of left atrial appendage occlusion in end stage renal disease patients: peri-procedural outcomes from an Italian dialysis population","volume":"262","author":"Genovesi","year":"2018","journal-title":"Int J Cardiol"},{"issue":"20","key":"10.1016\/j.jacep.2024.09.038_bib33","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.jcin.2017.07.044","article-title":"Association of chronic kidney disease with in-hospital outcomes of transcatheter aortic valve replacement","volume":"10","author":"Gupta","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"11","key":"10.1016\/j.jacep.2024.09.038_bib34","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.hrthm.2009.08.006","article-title":"Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation","volume":"6","author":"Aggarwal","year":"2009","journal-title":"Heart Rhythm"},{"issue":"3","key":"10.1016\/j.jacep.2024.09.038_bib35","first-page":"610","article-title":"Left atrial appendage closure in end-stage renal disease and hemodialysis: data from a German multicenter registry","volume":"101","author":"Fink","year":"2023","journal-title":"Catheter Cardiovasc Interv"},{"issue":"9","key":"10.1016\/j.jacep.2024.09.038_bib36","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.hrthm.2017.05.038","article-title":"Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial","volume":"14","author":"Boersma","year":"2017","journal-title":"Heart Rhythm"},{"issue":"17","key":"10.1016\/j.jacep.2024.09.038_bib37","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.4244\/EIJ-D-16-00726","article-title":"Transcatheter left atrial appendage occlusion in patients with atrial fibrillation and a high bleeding risk using aspirin alone for post-implant antithrombotic therapy","volume":"12","author":"Korsholm","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacep.2024.09.038_bib38","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6704031","article-title":"Left atrial appendage occlusion in high bleeding risk patients","volume":"2019","author":"Merella","year":"2019","journal-title":"J\u00a0Interv Cardiol"},{"issue":"7","key":"10.1016\/j.jacep.2024.09.038_bib39","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/europace\/euaa074","article-title":"Initial and long-term antithrombotic therapy after left atrial appendage closure with the WATCHMAN","volume":"22","author":"Ledwoch","year":"2020","journal-title":"Europace"},{"issue":"2","key":"10.1016\/j.jacep.2024.09.038_bib40","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1523-1755.2003.00101.x","article-title":"Elevated risk of stroke among patients with end-stage renal disease","volume":"64","author":"Seliger","year":"2003","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.jacep.2024.09.038_bib41","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1053\/j.ajkd.2013.10.013","article-title":"Risk of stroke in long-term dialysis patients compared with the general population","volume":"63","author":"Wang","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacep.2024.09.038_bib42","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijcard.2016.01.003","article-title":"Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation","volume":"207","author":"Kefer","year":"2016","journal-title":"Int J Cardiol"},{"issue":"12","key":"10.1016\/j.jacep.2024.09.038_bib43","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/ckj\/sfad221","article-title":"Long-term safety and efficacy of left atrial appendage occlusion in dialysis patients with atrial fibrillation: a multi-center, prospective, open label, observational study","volume":"16","author":"Genovesi","year":"2023","journal-title":"Clin Kidney J"},{"issue":"3 suppl 1","key":"10.1016\/j.jacep.2024.09.038_bib44","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2019.01.001","article-title":"US Renal Data System 2018 Annual Data Report: epidemiology of kidney disease in the United States","volume":"73","author":"Saran","year":"2019","journal-title":"Am J Kidney Dis"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X24008818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X24008818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T04:11:42Z","timestamp":1767240702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X24008818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2405500X24008818"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2024.09.038","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Left Atrial Appendage Occlusion in\u00a0Patients With Atrial Fibrillation and\u00a0Hemodialysis","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2024.09.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}